Document Detail


The polarization of immune cells in the tumour environment by TGFbeta.
MedLine Citation:
PMID:  20616810     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Transforming growth factor-beta (TGFbeta) is an immunosuppressive cytokine produced by tumour cells and immune cells that can polarize many components of the immune system. This Review covers the effects of TGFbeta on natural killer (NK) cells, dendritic cells, macrophages, neutrophils, CD8(+) and CD4(+) effector and regulatory T cells, and NKT cells in animal tumour models and in patients with cancer. Collectively, many recent studies favour the hypothesis that blocking TGFbeta-induced signalling in the tumour microenvironment enhances antitumour immunity and may be beneficial for cancer therapy. An overview of the current drugs and reagents available for inhibiting TGFbeta-induced signalling and their phase in clinical development is also provided.
Authors:
Richard A Flavell; Shomyseh Sanjabi; Stephen H Wrzesinski; Paula Licona-Limón
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2010-07-09
Journal Detail:
Title:  Nature reviews. Immunology     Volume:  10     ISSN:  1474-1741     ISO Abbreviation:  Nat. Rev. Immunol.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-23     Completed Date:  2010-09-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124169     Medline TA:  Nat Rev Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  554-67     Citation Subset:  IM    
Affiliation:
Yale University School of Medicine, 300 Cedar Street, TAC S-569, PO BOX 208011, New Haven, Connecticut 06520, USA. richard.flavell@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / pharmacology
Cell Polarity / immunology*
Cytokines / immunology
Dendritic Cells / immunology
Hematopoiesis, Extramedullary
Humans
Immunosuppression
Killer Cells, Natural / immunology
Macrophages / immunology
Neoplasms / immunology*,  therapy
Neutrophils / immunology
Signal Transduction / drug effects
T-Lymphocyte Subsets / immunology
T-Lymphocytes, Regulatory / immunology
Transforming Growth Factor beta / antagonists & inhibitors,  immunology*,  metabolism
Grant Support
ID/Acronym/Agency:
CA121974/CA/NCI NIH HHS; DK051665/DK/NIDDK NIH HHS; P50 CA121974/CA/NCI NIH HHS; //Howard Hughes Medical Institute
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Cytokines; 0/Transforming Growth Factor beta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Patient, surgical, and lens-related factors, and their association with Hydroview intraocular lens o...
Next Document:  Equal access.